MIG Capital logo

MIG Capital

Europe, Bayern, Germany, München

Description

MIG Capital, headquartered in Munich, Germany, stands as a leading European venture capital firm with a strong focus on early to mid-stage Deep Tech and Life Science companies. Established with a mission to back groundbreaking innovations, MIG Capital has built a reputation for identifying and nurturing disruptive technologies across various sectors, including biotechnology, medical technology, advanced materials, and cutting-edge software solutions. Their strategic approach emphasizes long-term partnerships with visionary founders, providing not just capital but also extensive operational support and access to a vast network of industry experts.

The firm's investment strategy is characterized by its capacity to deploy significant capital across a company's lifecycle. For initial investments, MIG Capital typically provides first cheques ranging from approximately $1.08 million (€1 million) to $5.4 million (€5 million). This initial commitment is often followed by substantial additional funding rounds, with total investments in a single portfolio company potentially reaching up to $16.2 million (€15 million) or more, demonstrating their commitment to scaling successful ventures. MIG Capital manages a substantial pool of capital, with assets under management exceeding $1.08 billion (€1 billion) across multiple funds, enabling them to support a diverse portfolio of high-potential startups.

MIG Capital boasts an impressive track record of success, having invested in over 40 companies since its inception. Their portfolio includes several notable success stories and exits that underscore their ability to pick winners. A prime example is the acquisition of Ganymed Pharmaceuticals by Astellas Pharma for a remarkable €422 million, highlighting MIG Capital's proficiency in identifying and scaling innovative biotech firms to significant exits. The firm is known for its hands-on involvement, offering strategic guidance, recruitment support, and market access to help their portfolio companies navigate complex growth phases and achieve their full potential.

This comprehensive support system, combined with their deep industry expertise and robust financial backing, positions MIG Capital as a preferred partner for ambitious deep tech and life science startups in Europe. Their commitment to fostering innovation and driving technological advancements continues to solidify their standing as a pivotal player in the European venture capital landscape.

Investor Profile

MIG Capital has backed more than 90 startups, with 4 new investments in the last 12 months alone. The firm has led 41 rounds, about 46% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in Germany, Austria, France.
  • Strong thematic focus on Biotechnology, Health Care, Manufacturing.
  • Led 1 rounds in the past year.
  • Typical check size: $1.1M – $5.4M.

Stage Focus

  • Series Unknown (33%)
  • Series A (27%)
  • Series B (18%)
  • Seed (9%)
  • Series C (7%)
  • Series D (4%)
  • Private Equity (1%)
  • Series E (1%)

Country Focus

  • Germany (78%)
  • Austria (8%)
  • France (6%)
  • Denmark (3%)
  • Canada (2%)
  • The Netherlands (2%)
  • Finland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Manufacturing
  • Software
  • Medical
  • Medical Device
  • Health Diagnostics
  • Information Technology
  • Semiconductor
  • Cleantech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MIG Capital frequently co-invest with?

NRW.BANK
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 4
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 9
BayBG Venture Capital
Europe, Bayern, Germany, München
Co-Investments: 4
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
GA
Europe, Bayern, Germany, Landshut
Co-Investments: 9
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 7
SV
Europe, Bayern, Germany, Holzkirchen
Co-Investments: 8
Santo Holding
Europe, Zurich, Switzerland, Zürich
Co-Investments: 6
S-Venture Capital Dortmund
Europe, Sachsen, Germany, Deutsch
Co-Investments: 4
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 5

Which angels does MIG Capital often collaborate with?

LS
Europe, Bayern, Germany, Munich
Shared Deals: 2
Hélène Huby
Europe, Bayern, Germany, Munich
Shared Deals: 1
Micheal Hyatt
North America, Ontario, Canada, Toronto
Shared Deals: 2
Mark Cowie
North America, Ontario, Canada, Toronto
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 1
AF
Europe, Bayern, Germany, Munich
Shared Deals: 1
DD
North America, Florida, United States, Naples
Shared Deals: 1
Shared Deals: 1
GW
North America, Florida, United States, Stuart
Shared Deals: 1
JB
Europe, Ile-de-France, France, Paris
Shared Deals: 1

What are some of recent deals done by MIG Capital?

ASTRA Therapeutics

Villigen, Aargau, Switzerland

ASTRA Therapeutics is a medication development business that uses cutting-edge science and technology.

Health CareTherapeutics
SeedJul 24, 2025
Amount Raised: $9,465,263
Look Up Space

Toulouse, Midi-Pyrenees, France

Look Up Space provide space safety and security data & services of unprecedented quality, with a sovereign and secure sensor network.

Cyber SecurityNetwork Security
Series AJun 11, 2025
Amount Raised: $27,396,697
CoreMedic GmbH

Radolfzell Am Bodensee, Baden-Wurttemberg, Germany

CoreMedic develops and manufactures devices to address the treatment of heart valve diseases. Lead product: ChordArt TMVr - System

Health CareManufacturingMedical Device
Series BFeb 11, 2025
Liva Healthcare

Copenhagen, Hovedstaden, Denmark

Liva Healthcare is a digital coaching platform that provides evidence-based coaching to manage and prevent chronic conditions.

AppsFitnessHealth CaremHealthSoftwareWellness
Series UnknownFeb 5, 2025
Inbolt

Paris, Ile-de-France, France

Real-time industrial robot guidance based on 3D vision

3D TechnologyIndustrial AutomationReal TimeRobotics
Series ASep 19, 2024
Amount Raised: $16,739,203
SciRhom

Martinsried, Bayern, Germany

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

BiotechnologyHealth Care
Series AJul 9, 2024
Amount Raised: $68,190,674
Innatera

Delft, Zuid-Holland, The Netherlands

Innatera is a developer of ultra-low-power intelligence for sensors.

Artificial Intelligence (AI)Machine LearningSemiconductor
Series AMar 19, 2024
Amount Raised: $16,292,553
HawkCell

Lyon, Rhone-Alpes, France

HawkCell is a medical research company that offers MRI solutions for veterinary clinics and preclinical research labs.

Life ScienceMedicalVeterinary
Series AMar 11, 2024
Amount Raised: $5,465,323
Look Up Space

Toulouse, Midi-Pyrenees, France

Look Up Space provide space safety and security data & services of unprecedented quality, with a sovereign and secure sensor network.

Cyber SecurityNetwork Security
SeedJun 21, 2023
Amount Raised: $7,694,168
AMSilk

Planegg, Bayern, Germany

AMSilk produces and distributes high-quality silk biopolymers.

BiotechnologyCosmetics
Series CApr 4, 2023
Amount Raised: $27,394,558